Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 262

1.

Mapping and Profiling Lipid Distribution in a 3D Model of Breast Cancer Progression.

Vidavsky N, Kunitake JAMR, Diaz-Rubio ME, Chiou AE, Loh HC, Zhang S, Masic A, Fischbach C, Estroff LA.

ACS Cent Sci. 2019 May 22;5(5):768-780. doi: 10.1021/acscentsci.8b00932. Epub 2019 Apr 19.

2.

Infant Formula Feeding Increases Hepatic Cholesterol 7α Hydroxylase (CYP7A1) Expression and Fecal Bile Acid Loss in Neonatal Piglets.

Mercer KE, Bhattacharyya S, Diaz-Rubio ME, Piccolo BD, Pack LM, Sharma N, Chaudhury M, Cleves MA, Chintapalli SV, Shankar K, Ronis MJJ, Yeruva L.

J Nutr. 2018 May 1;148(5):702-711. doi: 10.1093/jn/nxy038.

3.

Prevalence and factors associated with faecal impaction in the Spanish old population.

Serrano Falcón B, Álvarez Sánchez Á, Diaz-Rubio M, Rey E.

Age Ageing. 2017 Jan 12;46(1):119-124. doi: 10.1093/ageing/afw166.

PMID:
28181648
4.

Conclusions of the II International and IV Spanish Hydration Congress. Toledo, Spain, 2nd-4th December, 2015.

Aranceta-Bartrina J, Gil Á, Marcos A, Pérez-Rodrigo C, Serra-Majem L, Varela-Moreiras G, Drewnowski A, Palou A, Anadón A, Murray B, Gómez-Candela C, Maffeis C, Ramón D, Benton D, Corella D, Alonso-Aperte E, Martínez de Victoria E, O'Neal E, Pfeffer F, Braun H, Lukaski H, Polanco I, Bernal J, González-Alonso JS, Ordvás JS, del Coso J, Kenney L, Sardinha LB, Díaz-Rubio M, González-Gross M, Kapsokefalou MR, Sawka MN, Millard-Stafford M, Palacios N, Watson P, Riobó P, Urrialde R, Mora-Rodríguez R, Maughan RJ, Ortega RM, Gellert R, Oliver S, Trangmar S, Partearroyo T.

Nutr Hosp. 2016 Jul 13;33(Suppl 3):308. doi: 10.20960/nh.308. Erratum in: Nutr Hosp. 2016 Oct 11;33(5):1256.

5.

Implications of genotypic differences in the generation of a urinary metabolomics radiation signature.

Laiakis EC, Pannkuk EL, Diaz-Rubio ME, Wang YW, Mak TD, Simbulan-Rosenthal CM, Brenner DJ, Fornace AJ Jr.

Mutat Res. 2016 Jun;788:41-9. doi: 10.1016/j.mrfmmm.2016.03.003. Epub 2016 Mar 25.

6.

Contribution of Macromolecular Antioxidants to Dietary Antioxidant Capacity: A Study in the Spanish Mediterranean Diet.

Pérez-Jiménez J, Díaz-Rubio ME, Saura-Calixto F.

Plant Foods Hum Nutr. 2015 Dec;70(4):365-70. doi: 10.1007/s11130-015-0513-6.

PMID:
26482738
7.

Obtainment and characterization of a potential functional ingredient from olive.

Pérez-Jiménez J, Díaz-Rubio ME, Saura-Calixto F.

Int J Food Sci Nutr. 2015;66(7):749-54. doi: 10.3109/09637486.2015.1095863.

PMID:
26471073
8.

[Therapeutic update in hepatitis C].

Devesa MJ, Cuenca F, Izquierdo S, Sánchez-Pobre P, Ladero JM, López-Alonso G, Díaz-Rubio M, Rey E.

Rev Esp Quimioter. 2015 Sep;28 Suppl 1:48-51. Review. Spanish.

9.

Weight Gain and Somatization are Associated With the Onset of Gastroesophageal Reflux Diseases: Results of Two 5-year Follow-up Studies.

Barcelo M, Alvarez Sanchez A, Garcia Sanchez R, Diaz-Rubio M, Rey E.

J Clin Gastroenterol. 2016 Mar;50(3):202-7. doi: 10.1097/MCG.0000000000000364.

PMID:
26084009
10.

Regular consumption of an antioxidant-rich juice improves oxidative status and causes metabolome changes in healthy adults.

Díaz-Rubio ME, Pérez-Jiménez J, Martínez-Bartolomé MÁ, Álvarez I, Saura-Calixto F.

Plant Foods Hum Nutr. 2015 Mar;70(1):9-14. doi: 10.1007/s11130-014-0455-4.

PMID:
25481643
11.

A nation-wide study of prevalence and risk factors for fecal impaction in nursing homes.

Rey E, Barcelo M, Jiménez Cebrián MJ, Alvarez-Sanchez A, Diaz-Rubio M, Rocha AL.

PLoS One. 2014 Aug 22;9(8):e105281. doi: 10.1371/journal.pone.0105281. eCollection 2014.

12.

Need for infliximab dose intensification in Crohn's disease and ulcerative colitis.

Taxonera C, Olivares D, Mendoza JL, Díaz-Rubio M, Rey E.

World J Gastroenterol. 2014 Jul 21;20(27):9170-7. doi: 10.3748/wjg.v20.i27.9170.

13.

Is the reflux disease questionnaire useful for identifying GERD according to the Montreal definition?

Rey E, Barceló M, Zapardiel J, Sobreviela E, Muñoz M, Díaz-Rubio M.

BMC Gastroenterol. 2014 Jan 22;14:17. doi: 10.1186/1471-230X-14-17.

14.

Resistant starch intake partly restores metabolic and inflammatory alterations in the liver of high-fat-diet-fed rats.

Polakof S, Díaz-Rubio ME, Dardevet D, Martin JF, Pujos-Guillot E, Scalbert A, Sebedio JL, Mazur A, Comte B.

J Nutr Biochem. 2013 Nov;24(11):1920-30. doi: 10.1016/j.jnutbio.2013.05.008. Epub 2013 Sep 3.

PMID:
24011718
15.

Non-extractable polyphenols, a major dietary antioxidant: occurrence, metabolic fate and health effects.

Pérez-Jiménez J, Díaz-Rubio ME, Saura-Calixto F.

Nutr Res Rev. 2013 Dec;26(2):118-29. doi: 10.1017/S0954422413000097. Epub 2013 Aug 9. Review.

PMID:
23930641
16.

Validation of a questionnaire for assessing fecal impaction in the elderly: impact of cognitive impairment, and using a proxy.

Barcelo M, Jimenez-Cebrian MJ, Diaz-Rubio M, Rocha AL, Rey E.

BMC Geriatr. 2013 Mar 7;13:24. doi: 10.1186/1471-2318-13-24.

17.

Advantages of early cholecystectomy in clinical practice of a terciary care center.

Barcelo M, Cruz-Santamaria DM, Alba-Lopez C, Devesa-Medina MJ, Diaz-Rubio M, Rey E.

Hepatobiliary Pancreat Dis Int. 2013 Feb;12(1):87-93.

PMID:
23392804
18.

Relation of IL28B gene polymorphism with biochemical and histological features in hepatitis C virus-induced liver disease.

Agúndez JA, García-Martin E, Maestro ML, Cuenca F, Martínez C, Ortega L, Carballo M, Vidaurreta M, Agreda M, Díaz-Zelaya G, Suárez A, Díaz-Rubio M, Ladero JM.

PLoS One. 2012;7(5):e37998. doi: 10.1371/journal.pone.0037998. Epub 2012 May 29.

19.

Improved procedure to determine non-extractable polymeric proanthocyanidins in plant foods.

Zurita J, Díaz-Rubio ME, Saura-Calixto F.

Int J Food Sci Nutr. 2012 Dec;63(8):936-9. doi: 10.3109/09637486.2012.681634. Epub 2012 Apr 24.

PMID:
22524561
20.

Adalimumab reversed a severe lymphopenia in a patient with Crohn's disease.

Taxonera C, Mendoza JL, Ortega L, Pérez MI, Díaz-Rubio M.

J Crohns Colitis. 2012 May;6(4):488-91. doi: 10.1016/j.crohns.2011.10.016. Epub 2011 Dec 14.

PMID:
22398051
21.

Polymorphism of the TLR4 gene reduces the risk of hepatitis C virus-induced hepatocellular carcinoma.

Agúndez JA, García-Martín E, Devesa MJ, Carballo M, Martínez C, Lee-Brunner A, Fernández C, Díaz-Rubio M, Ladero JM.

Oncology. 2012;82(1):35-40. doi: 10.1159/000335606. Epub 2012 Jan 26.

PMID:
22286521
22.

Translation, cultural adaptation and validation of a Spanish version of the Irritable Bowel Syndrome Severity Score.

Almansa C, García-Sánchez R, Barceló M, Díaz-Rubio M, Rey E.

Rev Esp Enferm Dig. 2011 Dec;103(12):612-8. English, Spanish.

PMID:
22217344
23.

The burden and management of patients with IBS: Results from a survey in spanish gastroenterologists.

Almansa C, Díaz-Rubio M, Rey E.

Rev Esp Enferm Dig. 2011 Nov;103(11):570-5. English, Spanish.

24.

Mucosal healing for predicting clinical outcome in patients with ulcerative colitis using thiopurines in monotherapy.

López-Palacios N, Mendoza JL, Taxonera C, Lana R, López-Jamar JM, Díaz-Rubio M.

Eur J Intern Med. 2011 Dec;22(6):621-5. doi: 10.1016/j.ejim.2011.06.017. Epub 2011 Jul 27.

PMID:
22075292
25.

Predicting response to therapy in chronic hepatitis C: an approach combining interleukin-28B gene polymorphisms and clinical data.

Ladero JM, Martin EG, Fernández C, Carballo M, Devesa MJ, Martínez C, Suárez A, Díaz-Rubio M, Agúndez JA.

J Gastroenterol Hepatol. 2012 Feb;27(2):279-85. doi: 10.1111/j.1440-1746.2011.06834.x.

PMID:
21722179
26.

Beverages have an appreciable contribution to the intake of soluble dietary fibre: a study in the Spanish diet.

Diaz-Rubio ME, Saura-Calixto F.

Int J Food Sci Nutr. 2011 Nov;62(7):715-8. doi: 10.3109/09637486.2011.579950. Epub 2011 May 19.

PMID:
21591989
27.

Atypical symptoms of gastro-esophageal reflux during pregnancy.

Rey E, Rodríguez-Artalejo F, Herraiz MA, Alvarez-Sánchez A, Escudero M, Díaz-Rubio M.

Rev Esp Enferm Dig. 2011 Mar;103(3):129-32.

28.

Analysis of the REL polymorphism rs13031237 in autoimmune diseases.

Varadé J, Palomino-Morales R, Ortego-Centeno N, Díaz-Rubio M, Fernández-Gutiérrez B, González-Gay MÁ, Pascual-Salcedo D, Balsa A, Iglesias A, Gómez-García M, Witte T, Radstake TR, Coenen MJ, Urcelay E, Martín J.

Ann Rheum Dis. 2011 Apr;70(4):711-2. doi: 10.1136/ard.2010.134593. Epub 2010 Sep 27. No abstract available.

PMID:
20876593
29.

High prevalence of viable Mycobacterium avium subspecies paratuberculosis in Crohn's disease.

Mendoza JL, San-Pedro A, Culebras E, Cíes R, Taxonera C, Lana R, Urcelay E, de la Torre F, Picazo JJ, Díaz-Rubio M.

World J Gastroenterol. 2010 Sep 28;16(36):4558-63.

30.

CD40: novel association with Crohn's disease and replication in multiple sclerosis susceptibility.

Blanco-Kelly F, Matesanz F, Alcina A, Teruel M, Díaz-Gallo LM, Gómez-García M, López-Nevot MA, Rodrigo L, Nieto A, Cardeña C, Alcain G, Díaz-Rubio M, de la Concha EG, Fernandez O, Arroyo R, Martín J, Urcelay E.

PLoS One. 2010 Jul 12;5(7):e11520. doi: 10.1371/journal.pone.0011520. Erratum in: PLoS One. 2010;5(8). doi: 10.1371/annotation/4d830d1b-46ff-4d72-b577-6a3765d335fc.

31.

Study of chromosomal region 5p13.1 in Crohn's disease, ulcerative colitis, and rheumatoid arthritis.

Perdigones N, Martín E, Robledo G, Lamas JR, Taxonera C, Díaz-Rubio M, de la Concha EG, López-Nevot MA, García A, Gómez-García M, Fernández-Gutiérrez B, Martín J, Urcelay E.

Hum Immunol. 2010 Aug;71(8):826-8. doi: 10.1016/j.humimm.2010.05.010. Epub 2010 May 16.

PMID:
20561984
32.

NOD2/CARD15: geographic differences in the Spanish population and clinical applications in Crohn's disease.

Barreiro-de-Acosta M, Mendoza JL, Lana R, Domínguez-Muñoz JE, Díaz-Rubio M.

Rev Esp Enferm Dig. 2010 May;102(5):321-6.

33.

Predictive baseline criteria of primary therapeutic failure in chronic hepatitis C genotype 1.

Cuenca F, Fernández C, Devesa MJ, López-Alonso G, Mayol J, Suárez A, Ortega L, Díaz-Rubio M, Ladero JM.

Rev Esp Enferm Dig. 2010 Apr;102(4):234-8.

34.

STAT3 locus in inflammatory bowel disease and multiple sclerosis susceptibility.

Cénit MC, Alcina A, Márquez A, Mendoza JL, Díaz-Rubio M, de las Heras V, Izquierdo G, Arroyo R, Fernández O, de la Concha EG, Matesanz F, Urcelay E.

Genes Immun. 2010 Apr;11(3):264-8. doi: 10.1038/gene.2010.10. Epub 2010 Mar 4.

PMID:
20200543
35.

Non-invasive evaluation of the fibrosis stage in chronic hepatitis C: a comparative analysis of nine scoring methods.

Ladero JM, Delkader J, Ortega L, Fernández C, Devesa MJ, López-Alonso G, Mayol J, Cuenca F, Suárez A, Taxonera C, Díaz-Rubio M.

Scand J Gastroenterol. 2010;45(1):51-9. doi: 10.3109/00365520903305544.

PMID:
20030577
36.

Analysis of a non-synonymous single nucleotide polymorphism of the human diamine oxidase gene (ref. SNP ID: rs1049793) in patients with Crohn's disease.

López Palacios N, Agúndez JA, Mendoza JL, García-Martín E, Martínez C, Fuentes Ferrer ME, Ladero JM, Taxonera C, Díaz-Rubio M.

Scand J Gastroenterol. 2009;44(10):1207-12. doi: 10.1080/00365520903171250.

PMID:
19670078
37.

Effect of BSN-MST1 locus on inflammatory bowel disease and multiple sclerosis susceptibility.

Márquez A, Cénit MC, Núñez C, Mendoza JL, Taxonera C, Díaz-Rubio M, Bartolomé M, Arroyo R, Fernández-Arquero M, de la Concha EG, Urcelay E.

Genes Immun. 2009 Oct;10(7):631-5. doi: 10.1038/gene.2009.56. Epub 2009 Aug 6.

PMID:
19657358
38.

Onset and disappearance rates of gastroesophageal reflux symptoms in the Spanish population, and their impact on quality of life.

Rey E, Alvarez-Sánchez A, Rodríguez-Artalejo F, Moreno Elola-Olaso C, Almansa C, Díaz-Rubio M.

Rev Esp Enferm Dig. 2009 Jul;101(7):477-82.

39.

Constructive thinking, rational intelligence and irritable bowel syndrome.

Rey E, Moreno Ortega M, Garcia Alonso MO, Diaz-Rubio M.

World J Gastroenterol. 2009 Jul 7;15(25):3106-13.

40.

Role of ATG16L1 Thr300Ala polymorphism in inflammatory bowel disease: a Study in the Spanish population and a meta-analysis.

Márquez A, Núñez C, Martínez A, Mendoza JL, Taxonera C, Fernández-Arquero M, Díaz-Rubio M, de la Concha EG, Urcelay E.

Inflamm Bowel Dis. 2009 Nov;15(11):1697-704. doi: 10.1002/ibd.21001.

PMID:
19575361
41.

Novel association of the interleukin 2-interleukin 21 region with inflammatory bowel disease.

Márquez A, Orozco G, Martínez A, Palomino-Morales R, Fernández-Arquero M, Mendoza JL, Taxonera C, Díaz-Rubio M, Gómez-García M, Nieto A, López-Nevot MA, de la Concha EG, Martín J, Urcelay E.

Am J Gastroenterol. 2009 Aug;104(8):1968-75. doi: 10.1038/ajg.2009.224. Epub 2009 May 26.

PMID:
19471255
42.

Bioavailability of phenolic antioxidants associated with dietary fiber: plasma antioxidant capacity after acute and long-term intake in humans.

Pérez-Jiménez J, Serrano J, Tabernero M, Arranz S, Díaz-Rubio ME, García-Diz L, Goñi I, Saura-Calixto F.

Plant Foods Hum Nutr. 2009 Jun;64(2):102-7. doi: 10.1007/s11130-009-0110-7.

PMID:
19444613
43.

Specific association of a CLEC16A/KIAA0350 polymorphism with NOD2/CARD15(-) Crohn's disease patients.

Márquez A, Varadé J, Robledo G, Martínez A, Mendoza JL, Taxonera C, Fernández-Arquero M, Díaz-Rubio M, Gómez-García M, López-Nevot MA, de la Concha EG, Martín J, Urcelay E.

Eur J Hum Genet. 2009 Oct;17(10):1304-8. doi: 10.1038/ejhg.2009.50. Epub 2009 Apr 1.

44.

Oscillations in serum ferritin associated with antiviral therapy in chronic hepatitis C.

Ladero JM, López-Alonso G, Devesa MJ, Cuenca F, Ortega L, Agreda M, Suárez A, Ropero P, Díaz-Rubio M.

Rev Esp Enferm Dig. 2009 Jan;101(1):31-40. English, Spanish.

45.

FcRL3 gene promoter variant is associated with peripheral arthritis in Crohn's disease.

Mendoza JL, Lana R, Martin MC, de la Concha EG, Urcelay E, Diaz-Rubio M, Abreu MT, Mitchell AA.

Inflamm Bowel Dis. 2009 Sep;15(9):1351-7. doi: 10.1002/ibd.20895.

PMID:
19235910
46.

[Adalimumab induction and maintenance therapy for Crohn's disease. An open-label study].

López Palacios N, Mendoza JL, Taxonera C, Lana R, Fuentes Ferrer M, Díaz-Rubio M.

Rev Esp Enferm Dig. 2008 Nov;100(11):676-81. Spanish.

47.

Mycobacterium avium subspecies paratuberculosis and its relationship with Crohn's disease.

Mendoza JL, Lana R, Díaz-Rubio M.

World J Gastroenterol. 2009 Jan 28;15(4):417-22. Review.

48.

Prevalence of functional gastrointestinal disorders in patients with fibromyalgia and the role of psychologic distress.

Almansa C, Rey E, Sánchez RG, Sánchez AA, Díaz-Rubio M.

Clin Gastroenterol Hepatol. 2009 Apr;7(4):438-45. doi: 10.1016/j.cgh.2008.12.005. Epub 2008 Dec 13.

PMID:
19138763
49.

"12 weeks' stopping rule" in the treatment of genotype 1 chronic hepatitis C: two prognostic categories under the same label?

Ladero JM, López-Alonso G, Devesa MJ, Cuenca F, Agreda M, Ortega L, Suárez A, Díaz-Rubio M.

Scand J Gastroenterol. 2008 Aug;43(8):979-83.

PMID:
19086280
50.

Dietary fiber and antioxidant capacity in Fucus vesiculosus products.

Díaz-Rubio ME, Pérez-Jiménez J, Saura-Calixto F.

Int J Food Sci Nutr. 2009;60 Suppl 2:23-34. doi: 10.1080/09637480802189643. Epub 2008 Oct 25.

PMID:
18951280

Supplemental Content

Loading ...
Support Center